{
  "ticker": "4DX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02970495",
  "id": "02970495",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250718",
  "time": "0942",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250718/pdf/06lxgtrszjljpj.pdf",
  "summary": "### Material Information Summary (ASX:4DX)  \n\n- **Contract Renewal**: 3-year contract with University of Michigan Medical Center, valued at **AUD$155k**, granting access to 4DMedical\u2019s lung analysis products (LDAi, LDAf, PHA, investigational LTA).  \n- **Clinical Validation**: Multicentre study (published in *Respiratory Research*) validates XV LVAS\u00ae technology\u2019s ability to detect early small airways disease missed by conventional tests.  \n- **Grant Funding**: **AUD$1.1m** non-dilutive cash awarded via Australia\u2019s Economic Accelerator (AEA) for AI-driven respiratory biomarker development with academic partners.  \n\n*No material impact on capital structure, liquidity, or near-term trading. Focus on commercial/clinical traction.*",
  "usage": {
    "prompt_tokens": 1901,
    "completion_tokens": 170,
    "total_tokens": 2071,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-17T23:52:51.717303"
}